CHINA NT PHARMA GROUP CO LTD financial statements, including revenue, expenses, and profit
The total revenue of 1011 for the last semiannual is 7.23 M HKD, and it's 78.69% lower compared to the previous semiannual. The net income of H2 24 is -58.60 M HKD.